Oncogenic over-expression of MED12 is epigenetically fostered in the core-binding factor subgroups of acute myeloid leukemia

被引：0
|
作者：
Choudhury, Samrat Roy
Bhattacharya, Arkajyoti
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4762
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4762
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta
    Cairoli, Roberto
    Beghini, Alessandro
    Turrini, Mauro
    Bertani, Giambattista
    Nadali, Gianpaolo
    Rodeghiero, Francesco
    Castagnola, Carlo
    Lazzaroni, Francesca
    Nichelatti, Michele
    Ferrara, Felicetto
    Pizzolo, Giovanni
    Pogliani, Enrico
    Rossi, Giuseppe
    Martinelli, Giovanni
    Morra, Enrica
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (07) : 594 - 600
  • [32] Granulocytic sarcoma of Core-binding Factor (CBF) acute myeloid leukemia mimicking pancreatic cancer
    Schaefer, Henning Sebastian
    Becker, Heiko
    Schmitt-Graeff, Annette
    Luebbert, Michael
    LEUKEMIA RESEARCH, 2008, 32 (09) : 1472 - 1475
  • [33] Core binding factor acute myeloid leukemia
    Mouchel, Pierre Luc
    HEMATOLOGIE, 2015, 21 (01): : 91 - 94
  • [34] Core binding factor acute myeloid leukemia
    Paschka, Peter
    SEMINARS IN ONCOLOGY, 2008, 35 (04) : 410 - 417
  • [35] Animal modeling of core-binding factor translocations reveals contrasting phenotypes in progression to acute myeloid leukemia
    Kim, H
    Ko, R
    de Guzman-Strong, C
    Hiebert, SW
    Klug, CA
    BLOOD CELLS MOLECULES AND DISEASES, 2004, 33 (02) : 110 - 110
  • [36] Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia
    Salustiano-Bandeira, Maria L.
    Moreira-Aguiar, Amanda
    Pereira-Martins, Diego A.
    Coelho-Silva, Juan L.
    Weinhauser, Isabel
    Franca-Neto, Pedro L.
    Lima, Aleide S.
    Lima, Ana S.
    Baccarin, Anemari R.
    Silva, Fernanda B.
    de Melo, Manuela A.
    Niemann, Fernanda S.
    Nardinelli, Luciana
    Rojas, Cesar A. Ortiz
    Duarte, Bruno K.
    Araujo, Aderson S.
    Azevedo, Elisa A.
    Morais, Clarice N.
    Figueiredo-Pontes, Lorena L.
    Schuringa, Jan J.
    Huls, Gerwin
    Bendit, Israel
    Rego, Eduardo M.
    Saad, Sara T. Olalla
    Traina, Fabiola
    Bezerra, Marcos A.
    Lucena-Araujo, Antonio R.
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [37] t(9;22) as secondary alteration in core-binding factor de novo acute myeloid leukemia
    Vitale, Candida
    Lu, Xinyan
    Abderrahman, Balkees
    Takahashi, Koichi
    Ravandi, Farhad
    Jabbour, Elias
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (11) : E211 - E212
  • [38] Multidrug resistance (MDR) in acute myeloid leukemia (AML) with core-binding factor (CBF) abnormalities.
    Baer, MR
    O'Loughlin, KL
    Minderman, H
    Sait, SN
    Flood, JJ
    Sorci, JJ
    Stewart, CC
    BLOOD, 1999, 94 (10) : 64A - 64A
  • [39] Expression of core-binding factor (CBF) fusion genes in clonal evolution of chronic myeloid leukemia (CML).
    Kashani, FR
    Kantarjian, H
    Faderl, S
    O'Brien, S
    Rios, MB
    Cortes, J
    BLOOD, 2004, 104 (11) : 258B - 258B
  • [40] Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia
    Yucel, Orhan Kemal
    Alemdar, Mustafa Serkan
    Atas, Unal
    Undar, Levent
    CHEMOTHERAPY, 2021, 65 (5-6) : 166 - 170
12345